INSIGHTS ON DRUG DEVELOPMENT
-
![GettyImages-1767170794-GLP-1-peptide-chain]( "History Of Peptides In Medicine: From Early Chemistry To The GLP-1 Era")
History Of Peptides In Medicine: From Early Chemistry To The GLP-1 EraPeptide therapeutics from early chemical breakthroughs to today’s metabolic drugs, highlighting scientific, clinical, and manufacturing advances shaping modern drug development.
-
![Grace_AI Drug_OPCU_Feb_2026]( "Grace Capabilities Update February 2026: AI Drug Development")
Grace Capabilities Update February 2026: AI Drug DevelopmentDiscover support for your next small molecule drug substance program and learn how artificial intelligence and machine learning tools can be applied to accelerate API development.
-
![CRISPR Meets LNPs: A New Era In Cell And Gene Therapies]( "CRISPR Meets LNPs: A New Era In Cell And Gene Therapies")
CRISPR Meets LNPs: A New Era In Cell And Gene TherapiesExplore how lipid nanoparticles are revolutionizing non-viral gene editing with scalable, efficient delivery for both ex vivo and in vivo applications, which features new CRISPR-LNP data in T cells.
-
![data-analytics-edc-GettyImages-2150332083]( "The Analytical Advantage Across The Development Lifecycle")
The Analytical Advantage Across The Development LifecycleIntegrated, regulatory‑ready analytics help accelerate development, strengthen submissions, and ensure consistent product quality throughout the pharmaceutical lifecycle.
-
Fast And Accurate Detection Of Alzheimer's Disease Targets9/17/2024
In this study, the detection of three Alzheimer’s disease targets are highlighted: Human BDNF (Brain-derived neurotrophic factor), Tau, and TREM2 (Triggering receptor expressed on myeloid cells 2).
-
How Recent Trends Impact Bringing Your Molecule To Market7/9/2024
With accelerated approval times, growing competition between drugs, and a shift from hospital to home care, you’re under pressure to develop a delivery device in parallel with your drug.
-
5 Key Considerations For Companies Outsourcing Process Development6/9/2025
Venture capital in biotech remains strong post-pandemic, especially in cell and gene therapies. Discover five key factors to help companies choose between in-house and outsourced process development strategies.
-
Expanding The OSD Toolbox: An Industry Approach To Adsorb Lipids Onto Powder Substrates12/11/2024
Explore innovative solutions for improving the solubility and bioavailability of poorly soluble compounds in solid oral dosage forms to enhance drug delivery and therapeutic effectiveness.
-
Increasing Precision And Cost Efficiency In The Lab With Gas Mixing3/9/2026
Understanding how cells function drives progress in disease research and drug discovery. Precise control of cellular environments is essential for reliable experiments and therapeutic development.
DRUG DEVELOPMENT SOLUTIONS
-
![MabSelect VL Affinity Resin]( "Resin Offering High Productivity And Robust Processes")
MabSelect™ VL affinity resin uses a protein L ligand with strong affinity for the variable region of a human antibody’s kappa light chain. The resin offers high productivity and robust processes for affinity capture of bispecific antibodies and antibody fragments containing the kappa light chain and offers a good capture alternative for antibody variants that does not bind to protein A.
-
![GettyImages-640168692-laboratory-equipment-tablet-quality]( "Addressing Your Requirements For Parenteral Applications")
Ensure patient safety and product efficacy with high-quality pharmaceutical excipients that are designed to streamline regulatory approval and support sterile liquid drug formulation development.
-
![Chip-R1™]( "Chip-R1™ Rigid Chip")
Improve precision in ADME and Toxicology applications with a low-drug-absorption profile.
-
![MabSelect VL Affinity Resin]( "Protein L Resin For Affinity Capture")
MabSelect™ VL resin — protein L resin for affinity capture of antibody Fabs, bispecifics, and other variants containing a kappa light chain.
-
![GettyImages-1027587952-nurse-doctor-patient-comfort]( "Molecule To Cure. Fast.")
Everything we do for our customers is driven by an unswerving belief that ideas need to become solutions, molecules need to become cures, fast. Because humanity needs solutions, fast.
